[EN] BIARYL PYRAZOLES AS NRF2 REGULATORS<br/>[FR] BIARYL PYRAZOLES UTILISÉS COMME RÉGULATEURS DE NRF2
申请人:GLAXOSMITHKLINE IP DEV LTD
公开号:WO2017060854A1
公开(公告)日:2017-04-13
The present invention relates to biaryl pyrazole compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators.
本发明涉及双芳基吡唑化合物、它们的制备方法、含有它们的药物组合物及其作为NRF2调节剂的应用。
Biaryl pyrazoles as NRF2 regulators
申请人:GlaxoSmithKline Intellectual Property Development Limited
公开号:US10364256B2
公开(公告)日:2019-07-30
The present invention relates to biaryl pyrazole compounds of Formula (I)
methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators.
申请人:GlaxoSmithKline Intellectual Property Development
Limited
公开号:EP3551621A1
公开(公告)日:2019-10-16
BIARYL PYRAZOLES AS NRF2 REGULATORS
申请人:GlaxoSmithKline Intellectual Property Development Limited
公开号:US20180282349A1
公开(公告)日:2018-10-04
The present invention relates to biaryl pyrazole compounds of Formula (I)
methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators.
3-CARBOXYLIC ACID PYRROLES AS NRF2 REGULATORS
申请人:GLSXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
公开号:US20200031820A1
公开(公告)日:2020-01-30
The present invention relates to 3-carboxylic acid pyrrole compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators. In particular, the compounds of this invention include a compound of Formula (I):